For treatment costs, we assumed full adherence to medications, and derived medication costs directly from the Australian Pharmaceutical Benefits Scheme ( The most common SGLT2i in Australia in 2020 was empagliflozin
This is the evidence for a wider scope, which is why the role of the ingredient has become more prominent in this region, thereby supporting market progression
The World Mental Health (WMH) survey, using the WHO Composite International Diagnostic Interview (CIDI 3.0), identified BD as one of the most disabling psychiatric conditions, with affected individuals averaging 41.2 days of role impairment per year 36.5 of which were directly attributed to BD (Grande et al., 2016
Gently swirl the bottle until completely dissolvednever shake
Some users in community sources report sustained benefit at this stage
A healthcare provider can assess individual risk factors and recommend appropriate dosing strategies